Boehringer focuses on disease management
This article was originally published in Clinica
Executive Summary
Boehringer Mannheim is positioning itself as the foremost company in disease management. The German diagnostics and pharmaceutical company aims to reproduce its success in diabetes management in a number of further areas such as cancer, cardiovascular and bone diseases.